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Abstract 
Leptin, the product of ob gene, is an endocrine hor-
mone that regulates adipose tissue mass. Recently,
leptin has been found to generate a growth signal
involving a tyrosine kinase-dependent intracellular
pathway and promote angiogenic processes via
activation of leptin receptor (Ob-R) in endothelial
cells. However, it is not clear how leptin functions to
promote multi-step processes involved in the
neovascularization at the atherosclerotic plaque. We
have examined the
 
expression of matrix metallopro-
teinases (MMPs) and tissue inhibitors of metallopro-
teinases (TIMPs) and Ob-R in human atherosclerotic
lesions, leptin-mediated angiogenesis in vivo and in
vitro. Immunohistochemical analysis of human ath-
erosclerotic aorta revealed an increased expression
of Ob-R in the intima of neorevascularized regions
and of both MMPs and TIMPs predominantly in the
endothelial lining of intimal neovessels and mac-
rophages/foam cells. In the rat corneal angiogenesis
assay, leptin elicited a comparable sensitivity of
angiogenic activity to those of vascular endothelial
growth factor (VEGF). The immunohistological anal-
ysis of the leptin-treated rat cornea showed defini-
tive rises in Ob-R, MMPs and TIMPs expression as
well as those of VEGF receptor (VEGFR-1). Leptin
(10-40 ng/ml) induced proliferation of the human
umbilical vein endothelial cells (HUVECs) and eleva-
tion of MMP-2, MMP-9, TIMP-1, and TIMP-2 expres-
sion in a dose-dependent manner. Leptin also induced
increases of MMP-2, MMP-9, TIMP-1, and Up-regu-
lated the human coronary artery smooth muscle
cells (HCASMCs). These findings suggest that lep-
tin, a hormone with pluralistic properties including a
mitogenic activity on vascular endothelial cells, plays
a role in matrix remodeling by regulating the expres-
sion of MMPs and TIMPs. Taken together, our find-
ings further provide evidences for leptin’s role as an
angiogenesis inducer in the normal organ (rat cor-
nea) and in aberrant vasculature under duress like
atherosclerosis.
Keywords:
 leptin, angiogenesis, MMPs, atherosclerosis
Introduction
Leptin, the product of ob gene secreted by adipocytes
(Campfield et al., 1995; Halaas et al., 1995; Pelley-
mounter et al., 1995), has been known to generate a
growth signal involving a tyrosine kinase-dependent
intracellular pathway and act as a functional link
between adipocytes and the vasculature. Recently,
treatment of HUVECs with leptin enhanced formation of
capillary-like tubes in an in vitro angiogenesis assay and
neovascularization in an in vivo model of angiogenesis
(Bouloumié et al., 1998). Atherosclerotic diseases are
known to be closely associated with high levels of LDL
and obese state of patient and animals. However, any
involvement of leptin in the progression of athero-
sclerotic diseases has not been well understood
although neovascularization within the plaque has been
known to be essential in the atheromatous plaque
formation (Kahlon et al., 1992; O'Brien et al., 1994). 
It is not clear whether a circulating leptin could exert
paracrine effects on the plaque forming cells and
participate in the progression of atherosclerosis. We
have investigated the effects of leptin on vasculariz-
ation in vitro and in vivo and on the microenvironment
around the plaque by examining expression of tissue
modeling enzymes (MMPs) and inhibitors (TIMPs). We
have compared the effects of leptin in the aberrant
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tissue by examining the expression of Ob-R, VEGF and
MMPs/TIMPs in atheromatous plaques and in normal
tissue using angiogenesis-sensitive rat corneal model. 
Materials and Methods
Cell culture and proliferation assay 
Normal HUVECs and HCASMCs were purchased from
Clonetics and maintained in SmGM2 and EGMMV
bullet kits (Clonetics). HUVECs and HCASMCs from
passage 5 to 13 were used in this study. For the
proliferation assay, the cells in 24 wells were arrested
for 24 h in serum-free medium and then incubated in
serum−deprived medium supplemented with 2% FBS
for 72 h in the presence of increasing concentration of
leptin (10 to 40 ng/ml). Total cell number was counted
after trypsinization using a cell counter.
In vitro angiogenesis assay
Before the HUVECs were plated, the 24 well plates
coated with growth factor-reduced basement membrane
proteins (Matrigel, 0.3 ml/well) were solidified at 37oC for
1 h. Leptin was added to Matrigel solution prior to
polymerization. For angiogenesis assay with HUVECs,
the trypsinized cells were plated on the surface of
Matrigel and cultured in serum-deprived medium (8 × 104
cells/well). 
Measurement of VEGF165 and bFGF by ELISA
Expression of VEGF165 and bFGF by HUVECS and
HCASMCs after stimulation of leptin (10 to 40 ng/ml)
were measured by ELISA kit (R&D). The 100 ul of
standard or cultured medium was added into antibody-
coated wells of the microplate and incubated at 25oC for
2 h. The wells were washed 4 times with washing buffer
and incubated at 25oC for 2 h. The substrates were
added to the washed well and reacted for 20 min at
25oC. After adding the 50 ul of stop buffer, the concent-
rations of VEGF165 and bFGF were measured with
spectrophotometric reader at 450 nm. 
Zymography 
Enzymatic activities of MMP-2 and MMP-9 were investi-
gated using zymography analysis. The protein content
of the culture medium was measured by the method of
Bradford using bovine serum albumin as standard.
Aliquots of culture media containing 50 ug of protein
from HUVECs and HCASMCs, with or without leptin
treatment, were loaded on an 11% SDS-PAGE gel
containing 0.1% gelatin for electrophoresis. Gels were
reacted with collagenase buffer for 16 h at 37oC, stained
with 0.25% Coomassie brilliant blue, and destained with
30% isopropanol in 10% acetic acid to visualize the MMP
bands.
Western blot analysis
Fifty ug of protein was subjected to 8-12% gradient
SDS-PAGE gel and transferred to immobilon-P mem-
brane (Millipore, Bedford, MA) at 12 V for 1 h. The
membrane was blocked in 5% non-fat dry milk in TBS-
T at 25oC for 1 h. TIMP-2 antibody (5 ug/ml, 1 : 2000
dilution) and secondary antibody (goat anti-rabbit/mouse
IgG, horseradish peroxidase-conjugated, Amersham) was
used for the detection of TIMP-2. Signals were detected
with an ECL kit (Amersham), and exposed to X-ray film
(Kodak).
Analysis of the expression of MMPs by reverse
transcriptase-polymerase chain reaction (RT-PCR)
Total RNA was extracted from cultured cells and 5 µg of
purified total RNA was incubated with reverse transcript-
ase, dNTP, random hexamer and reaction buffer in a
final volume of 20 ul at 37oC for 1 h. After a final
denaturation at 94oC for 10 min, 10 ul of cDNA was
subjected to PCR consisting of a denaturation at 95oC
for 1 min, followed by 1 min of annealing at 55oC and 1
min of elongation at 72oC for 35 cycles. The primers for
amplification of MMP-1, -2, -9 and TIMP-1 were as
follows; MMP-1: sense 5'-ggaaaacacatggtgtgagtcc-3',
antisense: 5'-gttagaagagttatcccttgcc-3'; MMP-2: sense
5'-caggctcttctcctttcacaac-3', antisense 5'-aagccacggcttg-
gttttcctc-3'; MMP-9: sense 5'-tgggctacgtgacctatgacat-3',
antisense 5'-gcccagcccacctccactcctc-3'; TIMP-1: sense
5'-acccacagacggccttctgcaattc-3', antisense 5'-ggctatct-
gggaccgcagggactgc-3'. The amplified cDNA was size
fractionated by agarose gel electrophoresis. 
In vivo angiogenesis assay
Adult SD rats were anesthesized with ketamine and the
eye was topically anesthesized with oxybuprocaine.
With the use of an operating microscope, a central intra-
stromal linear keratotomy was performed with a surgical
blade. A lamellar micropocket was then dissected and
extended to within 2 mm of the superior limbus. Dehyd-
rated pellet (2 mm diameter) made of 70% hydratable
hydrogel containing PBS (n=4) or 125 ng of leptin (n=4)
were placed into the preformed corneal pocket. The
eyes were routinely examined by slit lamp biomicro-
scopy on day 7 after implantation. To analyze whether
the effect of cytokines on angiogenesis was direct or
due to infiltration by inflammatory cells, histological studies
were performed on sections after hematoxylin-eosin
staining.
Tissue preparation and histologic examination 
Immediately following the removal of human aortic seg-
ments (6 aortic dissections with atherosclerotic change
and 6 aortic aneurysms with atherosclerotic change,
median age; 54 years old) excluding dissection and
aneurysmal segment, each segment was perfused with
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10% formalin to maintain vascular integrity. The ather-
osclerotic change was confirmed microscopically. Two
normal aortic segments obtained by surgical repair for
traumatic aortic dissection were used as control (mean
age: 28 years old). 
Paraffin sections (5 µm) from human aortas and rat
cornea were made and transferred to slide glasses.
Slides were deparaffinized and rehydrated. Endogenous
peroxidase activity was blocked for 10 min at room
temperature in 50% volume H2O2/50% volume methanol
and rinsed in running tap water. Non-specific protein
binding sites were blocked by applying 5% normal goat
serum diluted in PBS/0.05% Tween 20 (pH 7.2-7.4) to
slides for 10 min at room temperature. The primary anti-
body (goat polyclonal antibodies for Ob-R; rabbit poly-
clonal antibodies for VEGF; goat polyclonal antibodies
for MMP-2; goat polyclonal antibodies for TIMP-2; rabbit
polyclonal antibodies for flk-1, Santa Cruz Biotechno-
logy, Inc., Santa Cruz, CA, USA) was diluted in 1%
normal goat serum in PBS/0.05% Tween 20, applied
and incubated overnight at 4oC in a humidity chamber.
Antibodies were directed against the carboxyl (C-20) or
the amino terminus (N-20) of Ob-R recognized a 170 kD
protein, the size of which is consistent with the human
leptin receptor. On day 2, the primary antibody was
rinsed off in tap water, blotted and the biotinylated
secondary antisera cocktail including goat anti-mouse
IgG and goat anti-rabbit diluted 1/400 was incubated on
the slides for 30 min at room temperature. Slides were
rinsed in running tap water, blotted and streptavidin-
horseradish peroxidase diluted 1/500 in PBS/0.05%
Tween 20 containing 1% normal goat serum was
applied and incubated for 30 min at room temperature.
The slides were rinsed in tap water and color developed
in 3-amino-9-ethylcarbazole substrate solution for 15
min at room temperature, then counterstained in
methylene blue for 30 s and covered with coverslip.
Statistical tests
Significance of values were determined with the 2-tailed
student’s t test. All results are expressed as the mean
± SEM.
Results
Cell proliferation study
The effect of leptin on HUVEC and HCASMC prolifer-
ation was shown in Figure 1. Treatment with leptin (10
to 40 ng/ml) stimulated HUVECs proliferation, but had
no significant effect on HCASMCs proliferation. These
differential effects of leptin on HUVECs and HCASMCs
are similar to the effect of VEGF. 
In vitro angiogenesis assay
As shown in Figure 2, HUVECs cultured on Matrigel
containing leptin (100 ng/ml) were stretched and elon-
gated forming a capillary-like structure within 4 h, but
HUVECs on untreated gel failed to form the capillary
structure. 
Effect of leptin on VEGF and bFGF expression
The concentrations of VEGF and bFGF after stimulation
with leptin (10 to 40 ng/ml) for 48 h were measured to
determine whether the angiogenic effect of leptin is
dependent on the other growth factors. As shown in
Figure 3, leptin enhanced the VEGF expression in a dose-
dependent manner from HUVECs, but not HCASMCs.
There was no significant change of bFGF expression in
both HUVEC and HCASMC (data not shown).
Effect of leptin on MMPs protein expression
MMP-2 and MMP-9 productions by HUVEC and HCASMC
were analyzed using zymography. The activities of MMP-
Figure 1. Effect of leptin on HUVECs and HCASMCs proliferation. HUVECs and HCASMCs were cultured in the presence of increasing concentration of
human recombinant leptin (A) or VEGF165 (B) for 72 h in serum-deprived medium. Data are presented as mean ± SEM. Three independent experiments were
performed. 
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2 and MMP-9 increased after treatment with leptin. The
activities of pro- and active MMP-2 were increased 1.5-
fold at the leptin concentration of 10 ng/ml, and 4-fold at
a higher concentration (20 or 40 ng/ml) in HUVECs
(Figure 4A). Total amount of MMP-9 secretion was
much lower than MMP-2 secretion and the effect of
leptin on MMP-9 secretion was less prominent. The
change of MMP-2 in HCASMCs was not as prominent
as in HUVECs. However, at a high concentration of
leptin (40 ng/ml), the activity of pro MMP-2 was increased
as shown in Figure 4B. 
Effect of leptin on HCASMCs MMPs and TIMPs
mRNA expression
The mRNA levels of MMP-2, MMP-9, and TIMP-1 by
HCASMCs were upregulated after leptin treatment (Figure
5A). The TIMP-2 protein expression by Western blot
analysis was also increased in the HCASMCs treated
with leptin (Figure 5B). 
Expression of Ob-R, VEGFR-1, and MMPs/TIMPs in
neovascularized atheromatous plaque
Control aortic tissues revealed little Ob-R (N-20, C-20)
immunoreactivity in intimal SMCs and infiltrated inflam-
matory cells. The VEGFR-1 immunoreactivity was also
weakly distributed in the endothelial lining with little non-
endothelial immunoreactivity. Compared to the control
aorta, the atherosclerotic aorta showed the increased
cellularity accompanied by the infiltration of inflamma-
Figure 2. Effect of leptin on the formation of capillary-like structures in cultured HUVECs in growth factor-reduced Matrigel. HUVECs plated on Matrigel and
cultured in serum free medium in the absence (A) or presence of 100 ng/ml human recombinant leptin (B). 
Figure 3. Effects of leptin on VEGF and bFGF secretion. Leptin up-
regulates the secretion of VEGF, but not bFGF by HUVECs. 
Figure 4. Effects of leptin on human MMP-2 and MMP-9 secretion. Leptin enhances MMP-2 secretion from both HUVECs and HCASMCs. Enzymatic activity
of human MMP-2 and MMP-9 were analyzed using SDS-PAGE gelatin zymography.
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tory cells, such as foam cells and neovascularization at
plaque base (Figure 6A). Atherosclerotic aortic plaques
demonstrated marked increase in Ob-R (C-20, N-20)
immunoreactivity, predominantly in foam cells, VSMCs
and the vascular endothelial lining of intimal neovessels
(Figure 6B, C). Tissue expression of Ob-R (N-20, C-20)
and VEGFR-1 were co-localized in atherosclerotic plaques
especially in non-endothelial cells such as foam cells
and vascular smooth muscle cells (VSMCs) (Figure 6D).
Furthermore, immunoreactivity of Ob-R and VEGFR-1
were co-expressed within neovascular endothelial cells.
The immunoreactivities for MMP-9 and TIMP-1 were
evident in the neovascular endothelial cells suggesting
that the expression of MMP has a role in the
neovascularization in atheromatous plaque (Figure 6E,
F).
In vivo angiogenesis assays and immunohisto-
chemistry
The former results suggest that leptin induces angio-
genesis through the endothelial proliferation and ex-
pression of MMPs. Thus, we used a rat corneal model
to evaluate the angiogenic property of leptin in vivo and
to investigate whether the expression of MMP is related
with angiogenic activity of leptin. Leptin at a dose of 125
ng/pellet promoted a new vessel growth, progressing
over half way to the lens by day 7 (Figure 7). Histologic
studies stained with hematoxylin & eosin demonstrated
that rat cornea treated with Hydron pellet containing
leptin revealed blood filled neovessels compared with
rat corneae treated with PBS pellets. Comparing pellet
with vehicle alone (Figure 8A), immunoreactivity of
MMP-2, MMP-9, TIMP-2 and VEGFR-1 were markedly
increased around the leptin-treated pellets (Figure 8B). 
Discussion 
In the present study, we have demonstrated the angio-
genic activity of leptin and its possible mechanisms
including indirect effect through the VEGF and effect on
the MMP. Leptin, the product of the ob gene secreted by
adipocytes, has been known to play a key role in the
regulation of body weight, reproduction, hematopoiesis,
and proinflammatory response (Bennett et al., 1996;
Gainsford et al., 1996; Conway and Jacobs, 1997;
Loffreda et al., 1998; Santos-Alvarez et al., 1999).
Leptin acting as a functional link between adipocytes
and the vasculature, might also play an important
extrahypothalamic role in the modulation of adipose
tissue mass. Recently, Sierra-Honigmann et al. (1998)
demonstrated that treatment of HUVECs with leptin
enhanced formation of capillary-like tubes in the in vitro
angiogenesis assay and neovascularization in the in
vivo
 model of angiogenesis. We hypothesized that the
overexpression of leptin has a role in the growth of
atheromatous plaques through its effect on neovascu-
larization. 
In atherosclerotic plaques, the immunoreactivity of Ob-
R increased especially in foam cells and VSMCs.
Interestingly, the immunoreactivity of VEGFR-1 was co-
localized in atheromatous plaques and observed in foam
cell-rich regions adjacent to the lipid core or the basal
regions of plaque consisting predominantly of VSMCs.
Ananyeva et al. (1997) recently demonstrated that ox-
LDL induced the release of aFGF from aFGF-transfect-
ed VSMCs. VEGF receptor (flt-1) expression in mono-
cyte and VSMCs has recently been confirmed; this
receptor mediates chemotaxis and tissue factor produc-
tion associated with up-regulation of MMPs to contribute
to the lateral expansion of new blood vessels. However,
the immunoreactivities of Ob-R, MMPs and their inhibi-
tors (TIMPs) increased in atherosclerotic plaques simul-
taneously with VEGFR-1, suggesting that the expres-
sion of VEGF is related with the increased activity of
leptin. The experimental study with rat corneas also
showed a prominent co-localization of Ob-R and
VEGFR-1 suggesting that the coupling of these factors
Figure 5. Effects of leptin on MMP-2, MMP-9, TIMP-1, and TIMP-2. The
PCR products from cDNA derived by RT-PCR of HCASMCs with primers
specific for MMP-2, MMP-9, and TIMP-1 were shown (A). Equal loading of
RNA was conformed by the PCR products of β-actin. The expression of
TIMP-2 was analyzed by the Western blot analysis (B).
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participates in neovascularization. The in vitro study
used to elucidate the effect of leptin on VEGF and bFGF
expression showed that leptin increased the secretion of
VEGF in HUVECs in a dose-dependent manner, but it
had little effect on the secretion of bFGF. However,
leptin has little effect on the secretion of VEGF165 or
bFGF in HCASMC. The differential effects on VEGF
according to the cell type need a further study. 
One of the initial steps in the angiogenesis process
involves the degradation of the subendothelial basement
membrane and surrounding extracellular matrix (ECM).
Following matrix breakdown, endothelial cells migrate
and proliferate to form new vessels, and proteolytic
enzymes that degrade ECM mediates this process. The
MMPs, a family of zinc-dependent proteinase, can
digest various ECM components, the requirement for
Figure 6. Hematoxylin & eosin stain of atherosclerotic lesion (panel A; final magnification, 100 x). Expression of the leptin receptor using a goat polyclonal
antibody directed against the amino (N-20)(panel B; 100 x), carboxyl (C-20)(panel C; 400 x) terminus of human Ob-R, immunoreactivity for VEGFR-1 (panel
D; 400 x), MMP-9 and TIMP-1 (panel E and F; 400 x) in atherosclerotic lesion. A strong immunostaining was seen in atherosclerotic plaque, mainly in foam
cells, vascular smooth muscle cells and the vascular endothelial lining of intimal neovessels (black arrows). 
Figure 7. In vivo angiogenic activity of leptin. Corneal response 7 days after implantation of a Hydron pellet containing PBS (A) or 125 ng of leptin (B). Arrow
indicates neovessels progressing from the limbus to the pellet.
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cellular migration. Wang and Keiser (1998) demon-
strated the enhancement of MMP expression in arterial
SMCs after VEGF stimulation. The vascular localization
of MMP may permit their spatial role in the degradation
of subendothelial basement membrane, which is a
crucial step in angiogenesis and atherosclerosis (Stetler-
Stevenson, 1999). MMPs are involved in more than the
breakdown of connective tissue barriers necessary for
new vessel formation. They also function to promote
angiogenesis by regulating endothelial cell attachment,
proliferation and migration of endothelial cells, either
directly or by release of growth factors sequestered in
the ECM. Moreover, new evidence suggests that MMPs
may also generate or release angiogenesis inhibitors
such as angiostatin from the ECM (Cornelius et al.,
1998). Among MMPs, MT-1-MMP and MMP-2 are active
on the endothelial cell surface and function immediately
in extracellular matrix turnover and regulation of cell-
ECM interactions. These changes in turnover of the ECM
may result in phenotypic changes associated with the
angiogenic response (Stetler-Stevenson, 1999). TIMP-2
binding to the active site of MT-1-MMP and the COOH-
terminal hemopexin-like domain of pro-MMP-2 results in
the formation of a ternary complex. If this occurs in
proximity to a second MT-1-MMP molecule, proteolytic
modification of the pro-fragment of MMP-2 initiates an
activation of this protease. The activated protease may
then dissociate from the cell surface and contribute to
degradation of the extracellular matrix prerequisite for
endothelial sprout invasion. Although recent studies
suggest the expression of leptin receptor in cell culture
study and nonvascular tissue, there was no information
about the interaction between leptin and MMPs/TIMPs
(Bouloumié et al., 1998; Sierra-Honigmann et al., 1998). 
In the present study, we demonstrated that the leptin
receptor was expressed in the human atheromatous
Figure 8. Immunohistochemical staining was performed with antibody for MMP-2, MMP-9, TIMP-1, TIMP-2, and VEGFR-1 (flt-1) in rat cornea on day 7 after
implantation of a Hydron pellet containing PBS (A) or 125 ng of leptin (B). Comparing with Hydron pellet containing PBS, rat cornea with leptin-treated pellet
reveals blood filled neovessels. Immunoreactivity for MMP-2, MMP-9, TIMP-2 and VEGFR-1 are markedly increased around the pellets containing leptin. Arrows
indicate neovessels. Lacunae in corneal tissue represent the sections of vessels. In controls, only a few vessels are noted, whereas in leptin-treated animals,
marked angiogenesis is obvious.
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plaques with neovascularization using polyclonal anti-
bodies to synthetic peptides based on the sequence of
human leptin receptor and leptin induced the prolife-
ration of endothelial cell and expression of MMPs/
TIMPs. In vitro study, the leptin increased the secretion
of VEGF in HUVECs in a dose dependent manner and
treatment with leptin on HUVECs and HCASMCs en-
hanced the expression of MMP-2, MMP-9, TIMP-1, and
TIMP-2 by Western blotting and RT-PCR. These find-
ings suggested that the leptin might be used as an
angiogenic factor or mitogenic factor of vascular endo-
thelial cells and play a role in matrix remodeling of
angiogenic process and on neovascularization micro-
environment. The present study might open a promising
perspective in regard to the future investigations of
leptin-MMPs dependent modulation of atherogenesis
and vascular neovascularization under pathophysiologi-
cal conditions. 
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